Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2342
2.720
Why?
Smoking
20
2019
1500
1.260
Why?
Bronchi
13
2018
249
1.210
Why?
Carcinoma in Situ
5
2019
45
1.110
Why?
Carcinoma, Squamous Cell
10
2018
627
0.770
Why?
Carcinogens
4
2012
110
0.760
Why?
Chemoprevention
3
2019
91
0.720
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
84
0.720
Why?
Lung
16
2020
3938
0.610
Why?
Carcinoma, Small Cell
7
2008
169
0.500
Why?
Bronchoscopy
9
2019
216
0.490
Why?
Urethane
3
2012
41
0.480
Why?
Bronchopulmonary Dysplasia
2
2019
379
0.470
Why?
Sputum
8
2019
302
0.460
Why?
Iloprost
2
2012
45
0.460
Why?
Pulmonary Alveoli
4
2012
403
0.460
Why?
Hyperplasia
7
2011
175
0.450
Why?
Precancerous Conditions
7
2020
160
0.440
Why?
Neprilysin
3
1998
48
0.420
Why?
Biomarkers, Tumor
7
2015
1164
0.400
Why?
Quinazolines
2
2012
243
0.390
Why?
Biopsy
11
2019
1088
0.390
Why?
Piperidines
2
2012
201
0.390
Why?
Antineoplastic Agents
4
2013
2046
0.390
Why?
DNA Copy Number Variations
1
2011
168
0.350
Why?
Bombesin
5
1998
11
0.350
Why?
Genetic Markers
1
2011
336
0.350
Why?
Amidohydrolases
3
1998
30
0.330
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1049
0.320
Why?
Neurosecretory Systems
4
2004
31
0.320
Why?
Ki-67 Antigen
3
2015
108
0.320
Why?
Tocopherols
1
2009
25
0.320
Why?
Isotretinoin
1
2009
23
0.320
Why?
Vasodilator Agents
1
2011
326
0.320
Why?
ErbB Receptors
1
2012
607
0.310
Why?
Mass Screening
3
2008
1190
0.300
Why?
Membrane Proteins
2
2008
1125
0.290
Why?
Neovascularization, Pathologic
6
2015
296
0.280
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
984
0.280
Why?
Respiratory Mucosa
2
2008
310
0.260
Why?
Adenocarcinoma
6
2012
893
0.250
Why?
Hypoxia
1
2012
1084
0.230
Why?
Chromosomes, Human, Pair 3
4
2000
48
0.220
Why?
Carcinoma, Bronchogenic
2
2002
19
0.210
Why?
Chromosome Aberrations
4
2013
147
0.210
Why?
Aged
25
2019
22061
0.210
Why?
Middle Aged
28
2019
31136
0.210
Why?
Tomography, Spiral Computed
1
2002
27
0.200
Why?
Humans
53
2020
129626
0.190
Why?
Female
33
2019
68734
0.190
Why?
Sensitivity and Specificity
10
2010
1843
0.190
Why?
Smokers
2
2019
138
0.180
Why?
Lung Diseases
5
2015
741
0.180
Why?
Double-Blind Method
2
2019
1875
0.180
Why?
Placebos
2
2019
201
0.180
Why?
Small Cell Lung Carcinoma
2
2012
88
0.180
Why?
Tomography, X-Ray Computed
2
2020
2512
0.170
Why?
Male
30
2019
63670
0.170
Why?
Neuropeptides
4
1998
71
0.160
Why?
Tumor Cells, Cultured
6
1998
943
0.160
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
99
0.160
Why?
Remission Induction
1
2019
274
0.150
Why?
Peptides
3
1996
926
0.150
Why?
In Situ Hybridization, Fluorescence
6
2010
313
0.150
Why?
Blotting, Western
4
2012
1206
0.140
Why?
Genes, p53
1
1997
70
0.140
Why?
Lung Diseases, Obstructive
1
1997
46
0.140
Why?
Antibodies, Monoclonal
3
2010
1366
0.140
Why?
Immunohistochemistry
8
2015
1685
0.130
Why?
Point Mutation
1
1997
224
0.130
Why?
Proteomics
2
2015
1055
0.130
Why?
Radiation Injuries, Experimental
1
1996
23
0.130
Why?
Bradykinin
1
1996
45
0.130
Why?
Endopeptidases
1
1996
86
0.120
Why?
Chromosomal Instability
2
2013
18
0.120
Why?
Mice
10
2012
16961
0.120
Why?
Animals
13
2013
35391
0.120
Why?
Smoking Cessation
1
2019
408
0.120
Why?
Hyperoxia
1
1996
90
0.120
Why?
Multiple Pulmonary Nodules
1
2015
19
0.120
Why?
Gene Expression
3
1998
1465
0.110
Why?
Risk Factors
5
2019
9786
0.110
Why?
Methylcholanthrene
2
2012
22
0.110
Why?
Antigens
1
1996
356
0.110
Why?
Butylated Hydroxytoluene
2
2012
38
0.110
Why?
Mice, Transgenic
5
2009
2128
0.110
Why?
Aged, 80 and over
8
2015
7052
0.110
Why?
Algorithms
3
2020
1616
0.110
Why?
Microarray Analysis
1
2013
116
0.110
Why?
Stem Cells
1
2018
575
0.110
Why?
Mutation
4
2000
3717
0.110
Why?
Epithelium
4
2018
314
0.100
Why?
Intramolecular Oxidoreductases
2
2004
67
0.100
Why?
Risk
5
2012
855
0.100
Why?
Carcinoma, Large Cell
1
2012
15
0.100
Why?
Biological Products
1
1996
205
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
151
0.100
Why?
Epithelial Cells
3
2007
1075
0.100
Why?
Receptors, Bombesin
1
2012
2
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
646
0.100
Why?
Volatile Organic Compounds
1
2012
57
0.090
Why?
Case-Control Studies
8
2012
3378
0.090
Why?
Immunoenzyme Techniques
1
2012
212
0.090
Why?
Cell Division
4
2000
796
0.090
Why?
Sleep Apnea Syndromes
1
2012
82
0.090
Why?
Veterans
1
2002
1375
0.090
Why?
Dose-Response Relationship, Drug
2
2010
2011
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2012
131
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
56
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
235
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
201
0.080
Why?
Antioxidants
2
2012
558
0.080
Why?
Proteins
1
1996
944
0.080
Why?
Cell Line
5
2013
2784
0.080
Why?
Plants, Toxic
1
1989
22
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Genome-Wide Association Study
2
2013
1326
0.080
Why?
Calcium
1
1996
1212
0.080
Why?
Predictive Value of Tests
4
2009
1947
0.080
Why?
Disease Progression
5
2018
2627
0.080
Why?
Cell Proliferation
2
2018
2373
0.080
Why?
Adult
16
2018
35599
0.080
Why?
Bronchial Neoplasms
1
2009
14
0.080
Why?
Chromosome Deletion
1
1989
104
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
441
0.080
Why?
Neoplasms, Glandular and Epithelial
1
2009
35
0.080
Why?
Airway Obstruction
3
2009
152
0.070
Why?
Respiratory System
1
1989
155
0.070
Why?
GPI-Linked Proteins
1
2008
68
0.070
Why?
Neoplasm Invasiveness
4
2015
481
0.070
Why?
Fluorescence
3
2009
155
0.070
Why?
Polymorphism, Genetic
1
2011
637
0.070
Why?
Alkaline Phosphatase
1
2008
146
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Isoenzymes
1
2008
301
0.070
Why?
Inflammation
1
2018
2750
0.070
Why?
Molecular Targeted Therapy
1
2010
391
0.070
Why?
Cell Transformation, Neoplastic
1
2009
326
0.070
Why?
Fibroblasts
3
1998
953
0.070
Why?
Molecular Sequence Data
5
1998
2835
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
259
0.070
Why?
Pulmonary Surfactants
2
1999
106
0.070
Why?
Exons
2
1998
342
0.070
Why?
Early Detection of Cancer
1
2010
370
0.060
Why?
Follow-Up Studies
2
2015
4894
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2060
0.060
Why?
MicroRNAs
1
2012
679
0.060
Why?
ROC Curve
3
2015
503
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
834
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
399
0.060
Why?
Recombinant Proteins
3
1998
1308
0.060
Why?
RNA, Messenger
3
1998
2708
0.060
Why?
Biomarkers
3
2010
3968
0.060
Why?
Polymerase Chain Reaction
3
1998
1035
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
24
0.060
Why?
Acromegaly
1
2004
13
0.060
Why?
Protein Kinase Inhibitors
1
2010
887
0.060
Why?
Cytokines
1
2012
2021
0.060
Why?
Adrenocorticotropic Hormone
1
2004
133
0.050
Why?
Rats
4
2004
5483
0.050
Why?
Neoplasm Recurrence, Local
1
2009
958
0.050
Why?
Smoke
1
2004
140
0.050
Why?
Base Sequence
3
1998
2147
0.050
Why?
Solitary Pulmonary Nodule
1
2002
20
0.050
Why?
Cross-Sectional Studies
2
2018
5075
0.050
Why?
Metaplasia
2
2018
57
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
530
0.050
Why?
Sex Factors
1
2007
1970
0.050
Why?
Hospitals, Veterans
1
2002
243
0.050
Why?
Radiation Dosage
1
2002
154
0.050
Why?
Pulmonary Fibrosis
2
1998
385
0.050
Why?
Reproducibility of Results
1
2008
3080
0.040
Why?
Gene Expression Regulation
1
1989
2542
0.040
Why?
Cohort Studies
4
2015
5426
0.040
Why?
Amino Acid Sequence
3
1994
2057
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Feasibility Studies
1
2002
869
0.040
Why?
Light
1
2001
359
0.040
Why?
Autocrine Communication
1
1998
43
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Desmoglein 3
1
2018
15
0.040
Why?
Signal Transduction
3
1998
4931
0.040
Why?
Loss of Heterozygosity
2
2013
46
0.040
Why?
DNA Primers
2
1998
511
0.040
Why?
Up-Regulation
2
2005
840
0.040
Why?
Bronchial Diseases
1
2018
37
0.040
Why?
Paracrine Communication
1
1998
61
0.040
Why?
Neoplasm Transplantation
1
1998
256
0.040
Why?
Gene Expression Profiling
1
2005
1687
0.040
Why?
Time
1
2018
76
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
37
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
28
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
14
0.040
Why?
Cell Cycle Checkpoints
1
2018
95
0.040
Why?
Genes, Tumor Suppressor
1
1998
87
0.040
Why?
Likelihood Functions
1
1998
137
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
97
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
69
0.040
Why?
DNA, Complementary
1
1998
270
0.040
Why?
Neoplasm Staging
2
2012
1282
0.040
Why?
Gene Expression Regulation, Enzymologic
1
1998
285
0.030
Why?
Codon
1
1997
86
0.030
Why?
United States
2
2011
13871
0.030
Why?
Introns
1
1998
251
0.030
Why?
Mice, Nude
1
1998
682
0.030
Why?
Treatment Outcome
1
2011
10219
0.030
Why?
Membrane Glycoproteins
1
1999
477
0.030
Why?
Incidence
3
2010
2641
0.030
Why?
Immunoassay
2
1998
107
0.030
Why?
Enzyme Activation
1
1998
813
0.030
Why?
RNA, Neoplasm
1
1996
86
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Mesothelioma
1
1996
38
0.030
Why?
Image Processing, Computer-Assisted
1
2020
740
0.030
Why?
Antigens, CD
2
1998
487
0.030
Why?
Machine Learning
1
2020
443
0.030
Why?
Sequence Analysis, DNA
1
1998
778
0.030
Why?
Proto-Oncogene Proteins
1
2018
636
0.030
Why?
Databases, Factual
1
2020
1269
0.030
Why?
Cell Cycle Proteins
1
2018
584
0.030
Why?
Myelin Sheath
1
1996
160
0.030
Why?
Receptors, Peptide
1
1994
17
0.030
Why?
Rh-Hr Blood-Group System
1
1994
11
0.030
Why?
Erythrocyte Membrane
1
1994
49
0.030
Why?
Blotting, Southern
1
1993
69
0.030
Why?
Prospective Studies
3
2012
7135
0.030
Why?
Blotting, Northern
1
1993
201
0.030
Why?
Neoplasm Metastasis
1
1996
611
0.030
Why?
Endoscopy
1
2015
288
0.030
Why?
DNA, Neoplasm
1
1993
157
0.030
Why?
Cells, Cultured
2
2007
4084
0.030
Why?
Solid Phase Microextraction
1
2012
8
0.030
Why?
Liver Neoplasms
1
1998
639
0.030
Why?
Fluorescent Antibody Technique
1
1993
376
0.020
Why?
Dinoprostone
2
2004
187
0.020
Why?
Colorado
1
2002
4404
0.020
Why?
Enzyme Inhibitors
1
1996
827
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
130
0.020
Why?
Cloning, Molecular
1
1993
525
0.020
Why?
Breath Tests
1
2012
87
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2018
1336
0.020
Why?
Iceland
1
2011
10
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Spain
1
2011
34
0.020
Why?
Respiratory Tract Diseases
1
1992
148
0.020
Why?
Netherlands
1
2011
77
0.020
Why?
Cattle
1
1993
977
0.020
Why?
Administration, Oral
1
2012
787
0.020
Why?
Rats, Sprague-Dawley
1
1996
2395
0.020
Why?
Meta-Analysis as Topic
1
2011
170
0.020
Why?
Severity of Illness Index
1
2018
2739
0.020
Why?
Carrier Proteins
1
1994
745
0.020
Why?
Prognosis
2
2012
3774
0.020
Why?
Receptor, IGF Type 1
1
2009
64
0.020
Why?
Flow Cytometry
1
1993
1159
0.020
Why?
Area Under Curve
1
2010
304
0.020
Why?
International Agencies
1
2009
29
0.020
Why?
Cystic Fibrosis
1
1998
1066
0.020
Why?
Erythrocytes
1
1994
673
0.020
Why?
Pilot Projects
1
2012
1592
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
580
0.020
Why?
Mass Spectrometry
1
2010
714
0.020
Why?
Genome, Human
1
2009
394
0.020
Why?
Models, Statistical
1
2010
625
0.020
Why?
Amino Acids
1
1989
487
0.020
Why?
Genotype
1
2011
1833
0.020
Why?
Disease Models, Animal
1
1996
4078
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
107
0.010
Why?
Genomics
1
2009
718
0.010
Why?
Epoprostenol
1
2004
136
0.010
Why?
Bronchiolitis
1
2004
90
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
949
0.010
Why?
Autoantibodies
1
2010
1468
0.010
Why?
Fruit
1
2003
133
0.010
Why?
Pituitary Neoplasms
1
2004
179
0.010
Why?
Vegetables
1
2003
148
0.010
Why?
Genetic Predisposition to Disease
1
2011
2274
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
756
0.010
Why?
Respiratory Function Tests
1
2004
581
0.010
Why?
Adenoma
1
2004
214
0.010
Why?
Regression Analysis
1
2003
997
0.010
Why?
Single-Blind Method
1
2001
271
0.010
Why?
Weight Gain
1
2004
509
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
55
0.010
Why?
Carcinoma
1
2001
214
0.010
Why?
RNA
1
2005
882
0.010
Why?
Bronchoscopes
1
1998
2
0.010
Why?
Endoglin
1
1998
19
0.010
Why?
Random Allocation
1
1998
347
0.010
Why?
Retrospective Studies
1
2015
14522
0.010
Why?
Genetic Linkage
1
1998
298
0.010
Why?
Reference Values
1
1998
794
0.010
Why?
Comorbidity
1
2001
1547
0.010
Why?
Longitudinal Studies
1
2003
2720
0.010
Why?
Linear Models
1
1998
819
0.010
Why?
Tumor Suppressor Protein p53
1
2000
507
0.010
Why?
Diet
1
2003
1213
0.010
Why?
Receptors, Cell Surface
1
1998
381
0.010
Why?
Analysis of Variance
1
1998
1293
0.010
Why?
Alleles
1
1998
847
0.010
Why?
Young Adult
1
2011
12455
0.010
Why?
Infant, Premature
1
1998
542
0.010
Why?
Risk Assessment
1
2004
3262
0.010
Why?
Chromatography, Affinity
1
1994
83
0.010
Why?
CD47 Antigen
1
1994
28
0.010
Why?
Endothelium, Vascular
1
2000
903
0.010
Why?
Genes
1
1994
227
0.010
Why?
Moths
1
1994
39
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
327
0.010
Why?
Cytoplasm
1
1994
269
0.010
Why?
Chromosome Mapping
1
1994
505
0.010
Why?
Carcinoid Tumor
1
1992
24
0.010
Why?
Adolescent
1
2011
20412
0.010
Why?
Lymphocytes
1
1994
378
0.010
Why?
Transfection
1
1994
915
0.010
Why?
Mice, Inbred BALB C
1
1994
1250
0.010
Why?
Dyspnea
1
1992
239
0.010
Why?
Binding Sites
1
1994
1248
0.010
Why?
Fibrosis
1
1992
526
0.010
Why?
Phenotype
1
1998
3075
0.000
Why?
Aging
1
1998
1778
0.000
Why?
Infant, Newborn
1
1998
5756
0.000
Why?
Infant
1
1998
8995
0.000
Why?
Child, Preschool
1
1998
10490
0.000
Why?
Child
1
1998
20884
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)